HomeCTOR • NASDAQ
add
Citius Oncology Inc
Previous close
$1.17
Day range
$1.15 - $1.25
Year range
$0.85 - $4.42
Market cap
85.86M USD
Avg Volume
106.48K
P/E ratio
4.96
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 6.39M | 39.52% |
Net income | -6.66M | -40.86% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | -4.13% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 112.00 | — |
Total assets | 90.48M | 89.55% |
Total liabilities | 49.19M | 96.69% |
Total equity | 41.29M | — |
Shares outstanding | 71.55M | — |
Price to book | 2.02 | — |
Return on assets | -18.29% | — |
Return on capital | -33.65% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -6.66M | -40.86% |
Cash from operations | 0.00 | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | 2.40M | 39.52% |
About
Founded
2021
Website
